Sequent Scientific Ltd share price logo

Sequent Share Price (SEQUENT)

Check the latest share price of Sequent, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.

₹197.261.37%

as on 04:01PM, 13 Jun 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Sequent Stock Performance

Get live Sequent share price, day's high and low, historical returns, and market stats.

  • Day's Low

    Day's High

    ₹186.2
    Day's Price Range
    ₹198.21
  • 52 Week's Low

    52 Week's High

    ₹116.4
    52-Week Price Range
    ₹240.7
1 Month Return+ 13.15 %
3 Month Return+ 50.44 %
1 Year Return+ 60.58 %
3 Year Return+ 96.96 %
5 Year Return+ 131.66 %
Previous Close₹194.60
Open₹188.00
Volume8.73L
Upper Circuit₹233.52
Lower Circuit₹155.68

Sequent Fundamentals & Key Indicators

Check Sequent market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹4,937.46 Cr

Return on Equity (ROE)

0.22

PE Ratio (TTM)

224.16

Return on capital employed (ROCE)

0.52

Industry PE ratio

57.39

Beta (LTM)

1.51

P/B Ratio

2.65

Dividend Yield

0

PEG Ratio

96.21

Quarterly Earnings Growth YOY

717.32

EPS (TTM)

-1.19

Sector

Pharmaceuticals

Book Value

26.32

Technical Analysis

How to invest in Sequent?

Investing in Sequent is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Sequent or SEQUENT on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Sequent or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Sequent with just a few clicks!

Sequent Stock's Interest Amongst Investors

80%

Period Jun 14, 2025 to May 15, 2025. Change in 30 Days vs previous period

Search interest for Sequent Scientific Ltd Stock has increased by 80% in the last 30 days, reflecting an upward trend in search activity.

Sequent Valuation

Track how Sequent P/E has moved over time to understand its valuation trends.

Sequent in the last 5 years

  • Overview

  • Trends

Lowest (-117.80x)

January 17, 2023

Industry (57.39x)

June 13, 2025

Today (224.16x)

June 13, 2025

Highest (1034.67x)

September 27, 2024

LowHigh

Today’s Price to Earnings Ratio: 224.16x

Sequent Share Price Target

Get share price movements and forecasts by analysts on Sequent.

Excluding Excise Duty and Other Income, represents Net Revenue

Sequent revenue growth forecast

Expected growth rate , :0

Forecast

Actual

Source: S&P Global Market Intelligence

Sequent Financial Results

Get the annual and quarterly financial summary of Sequent, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25
Revenue

(in ₹ Cr)

361 (0%)390 (8%)369 (6%)391 (6%)402 (3%)
Net Income

(in ₹ Cr)

1 (0%)9 (613%)6 (30%)6 (2%)10 (60%)
Net Profit Margin0.35% (0%)2.32% (563%)1.72% (26%)1.66% (3%)2.58% (55%)
Value in ₹ crore
DetailsFY21FY22FY23FY24
Total Assets

(in ₹ Cr)

1109 (0%)1127 (2%)1123 (0%)1188 (6%)
Total Liabilities

(in ₹ Cr)

79 (0%)85 (7%)65 (24%)100 (55%)
Value in ₹ crore
DetailsFY20FY21FY22FY23FY24
Operating Cash Flow

(in ₹ Cr)

30 (0%)2 (92%)9 (300%)38 (303%)-27 (171%)

Indices Featuring Sequent Stock

Check stock indices that include Sequent.

BSE Small-Cap

₹53,370.29

-0.3 (-161.18%)

BSE Healthcare

₹43,995.31

0.08 (34.42%)

Sequent Earnings and Dividends

View detailed summary of the earnings and dividend history of Sequent.

  • Sequent Scientific Ltd Earnings Results

    Sequent Scientific Ltd’s net profit jumped 1113.04% since last year same period to ₹9.32Cr in the Q4 2024-2025. On a quarterly growth basis, Sequent Scientific Ltd has generated 170.93% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Sequent Scientific Ltd Dividends June,2021

    In the quarter ending March 2021, Sequent Scientific Ltd has declared dividend of ₹0.50 - translating a dividend yield of 0.25%.

    Read More about Dividends

Sequent Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Sequent.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
52.61%
0.00
Foreign Institutions
6.05%
0.00
Mutual Funds
10.22%
0.00
Retail Investors
28.36%
0.00
Others
2.76%
0.00

Sequent vs Peers

Compare market cap, revenue, PE, and other key metrics of Sequent with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA4,937.4626.33%0.52-301,369
NA6.245.19%5.69NANA
NA81.5858.65%0.51140
NA1,949.0625.81%0.5158630
NA69.916.88%0.78245

Sequent News & Key Events

Latest news and events in one place to help you make informed investing decisions in Sequent.

  • SeQuent Scientific and Viyash Merger Progresses - 29 May, 2025

    SeQuent Scientific has received stock exchange approvals for its merger with Viyash Life Sciences. The merger aims to enhance SeQuent's position in animal health, doubling its scale and capabilities. Shareholders of Viyash will receive SeQuent shares in exchange for their holdings.
  • Sequent Scientific Reports Strong Q1 2025 Financials - 21 May, 2025

    Sequent Scientific's standalone net sales for March 2025 reached Rs 42.33 crore, up 15.12% YoY. Net profit rose 12.41% to Rs 4.23 crore, while EBITDA increased by 30.52%. EPS improved to Rs 0.17. However, shares have declined 12.04% over the last six months.
  • Sequent Scientific Reports Strong Q4 and FY25 Results - 20 May, 2025

    Sequent Scientific Limited reported a net profit of ₹9.32 crore for Q4 FY25, a significant turnaround from a loss last year. For FY25, net profit reached ₹44.3 crore, with revenue growing 13.3% year-on-year to ₹1,551.4 crore, reflecting improved operational efficiency.

Insights on Sequent Scientific Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 9.58% to 10.22% in Mar 2025 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 373.16 Cr → 403.36 Cr (in ₹), with an average increase of 3.8% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, SEQUENT stock has moved up by 50.4%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, SEQUENT has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 2.61 Cr → 9.32 Cr (in ₹), with an average increase of 43.6% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 131.1% return, outperforming this stock by 34.1%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 52.61% of holdings in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 29.11% to 28.36% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 6.10% to 6.05% in Mar 2025 quarter

About Sequent

Visistha Traders Finance Ltd has combined itself with PI Drugs and Pharmaceuticals Ltd. Confirmation of amalgamation was approved by the High Court on November 12th 2003. As a result, one of the leading companies in the Indian pharmaceutical industry is now under its wing. It is anticipated that the move will benefit both the companies, shareholders and society at large. It will help Visistha Traders further solidify its creative and enterprising portfolio while aiding PI Drugs expand its reach and customer base. The amalgamation will make it easier to access the required resources, human and capital in a more efficient manner. Another positive factor of this step is that it will reduce administrative costs, allowing for a more productive use of resources. Combining the skill sets of both firms also ensures the sector benefits the most efficient and cutting-edge solutions. All in all, this is a step that is expected to lead to a brighter future for the pharmaceutical sector.

Revenue: ₹401.70Cr as on March 2025 (Q4 FY25)
Net Profit: ₹10.38Cr as on March 2025 (Q4 FY25)
Listing date: 10 Mar, 2016
Chairperson Name: Kamal K Sharma
OrganisationSequent Scientific Ltd
HeadquartersBangalore
IndustryPharmaceuticals
CEOKamal K Sharma
E-voting on sharesClick here to vote

FAQs

What is Sequent share price today?

Sequent share price today stands at ₹197.26, Open: ₹188, Previous Close: ₹194.6, High: ₹198.21, Low: ₹186.2, 52 Week High: ₹240.7, 52 Week Low: ₹116.4.

What is today's traded volume of Sequent?

Today's traded volume of Sequent is 8.73L. Which means that 8.73L shares of Sequent were bought and sold on the stock market during today's trading session.

What is Sequent's market cap today?

Today's market capitalisation of Sequent is ₹4,937.46 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Sequent?

Sequent’s 52 week high is ₹240.7 and 52 week low is ₹116.4. The current share price of Sequent is ₹197.26, which is -18.05% down from its 52 week high and 69.47% up from its 52 week low.